Q4 2019 Syndax Pharmaceuticals Inc Earnings Call Transcript
Good day, everyone, and welcome to the Syndax Fourth Quarter 2019 Earnings Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Claudia Styslinger of Argot Partners. Please begin.
Thank you, operator. Welcome, and thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax' fourth quarter and full year 2019 financial and operating results.
I'm Claudia Styslinger with Argot Partners. And with me this afternoon to discuss the results and provide an update on the company's progress are Dr. Briggs Morrison, Chief Executive Officer; and Rick Shea, Chief Financial Officer. Also joining us on the call today for the question-and-answer session are Michael Metzger, President and Chief Operating Officer; and Dr. Michael Meyers, Chief Medical Officer.
This call is being accompanied by a slide deck that has been posted on the company's website, so I'd ask you to please turn to our forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |